Xingtong Wang

No. 71. Xinmin Street
Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Glofitamab for the treatment of relapsed/refractory hairy cell leukemia: a case report.

Journal: Leukemia & lymphoma
Published: July 06, 2026

Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study.

Obinutuzumab versus rituximab-based chemotherapy in high-tumor burden indolent B-cell lymphoma: a real-world comparative study.

Journal: Frontiers in immunology
Published: April 16, 2026

Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.

Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.

Journal: International journal of cancer
Published: October 27, 2025

Autoimmune disease-associated lymphomas: research progress and review.

Autoimmune disease-associated lymphomas: research progress and review.

Journal: Frontiers in immunology
Published: October 06, 2025

Real-world analysis of primary central nervous system diffuse large B-cell lymphoma.

Real-world analysis of primary central nervous system diffuse large B-cell lymphoma.

Journal: Critical reviews in oncology/hematology
Published: April 04, 2025

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model.

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model.

Journal: Oncogene
Published: January 31, 2025

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice.

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice.

Journal: Science advances
Published: October 23, 2024

A retrospective study on the efficacy of pegfilgrastim-filgrastim combination regimen in the mobilization for autologous stem cell transplantation in lymphoma patients.

A retrospective study on the efficacy of pegfilgrastim-filgrastim combination regimen in the mobilization for autologous stem cell transplantation in lymphoma patients.

Journal: The American journal of the medical sciences
Published: June 10, 2023

S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma.

S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: September 22, 2022

Improving the prognostic ability of PET/CT SUVmax to identify follicular lymphoma with early treatment failure.

Improving the prognostic ability of PET/CT SUVmax to identify follicular lymphoma with early treatment failure.

Journal: American journal of cancer research
Published: June 06, 2022

Overdrive pacing in the acute management of osimertinib-induced ventricular arrhythmias: A case report and literature review.

Overdrive pacing in the acute management of osimertinib-induced ventricular arrhythmias: A case report and literature review.

Journal: Frontiers in cardiovascular medicine
Published: May 02, 2022

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China.

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China.

Journal: Frontiers in oncology
Published: February 14, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026